Femasys Inc. (FEMY)
NASDAQ: FEMY · Real-Time Price · USD
0.7663
+0.0363 (4.97%)
At close: Aug 13, 2025, 4:00 PM
0.8000
+0.0337 (4.40%)
After-hours: Aug 13, 2025, 6:06 PM EDT
Femasys Employees
As of December 31, 2024, Femasys had 71 total employees, including 69 full-time and 2 part-time employees. The number of employees increased by 37 or 108.82% compared to the previous year.
Employees
71
Change (1Y)
37
Growth (1Y)
108.82%
Revenue / Employee
$26,578
Profits / Employee
-$295,990
Market Cap
24.96M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
FEMY News
- 5 days ago - Femasys Announces Second Quarter Financial Results for 2025 - GlobeNewsWire
- 7 days ago - Femasys Secures First European Order for FemBloc, Marking Strategic Milestone in Global Expansion - GlobeNewsWire
- 6 weeks ago - Femasys Achieves Australian and New Zealand Regulatory Approvals for FemaSeed® for First-Line Infertility Treatment and FemVue Diagnostic - GlobeNewsWire
- 7 weeks ago - Femasys Announces Historic Milestone with European Approval of FemBloc®, the First Non-Surgical Permanent Birth Control - GlobeNewsWire
- 2 months ago - Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth - GlobeNewsWire
- 2 months ago - Femasys Announces Partnership with Carolinas Fertility Institute, One of America's Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations - GlobeNewsWire
- 2 months ago - Femasys Announces Proposed Public Offering of Common Stock and Concurrent Private Placement - GlobeNewsWire
- 3 months ago - Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update - GlobeNewsWire